Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9962)
All Articles published online
|
Publishing Process of This Article
|
Jun 21, 2014 (publication date) through Dec 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Giannitrapani L, Soresi M, Bondì ML, Montalto G, Cervello M. Nanotechnology applications for the therapy of liver fibrosis. World J Gastroenterol 2014; 20(23): 7242-7251 [PMID: 24966595 DOI: 10.3748/wjg.v20.i23.7242] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i23/7242.htm |
| Number | Citing Articles |
| 1 |
Maria Luisa Bondì, Angela Scala, Giuseppe Sortino, Erika Amore, Chiara Botto, Antonina Azzolina, Daniele Balasus, Melchiorre Cervello, Antonino Mazzaglia. Nanoassemblies Based on Supramolecular Complexes of Nonionic Amphiphilic Cyclodextrin and Sorafenib as Effective Weapons to Kill Human HCC Cells. Biomacromolecules 2015; 16(12): 3784 doi: 10.1021/acs.biomac.5b01082
|
| 2 |
Haolu Wang, Camilla A. Thorling, Xiaowen Liang, Kim R. Bridle, Jeffrey E. Grice, Yian Zhu, Darrell H. G. Crawford, Zhi Ping Xu, Xin Liu, Michael S. Roberts. Diagnostic imaging and therapeutic application of nanoparticles targeting the liver. Journal of Materials Chemistry B 2015; 3(6): 939 doi: 10.1039/C4TB01611D
|
| 3 |
Maria Luisa Bondì, Chiara Botto, Erika Amore, Maria Rita Emma, Giuseppa Augello, Emanuela Fabiola Craparo, Melchiorre Cervello. Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells. International Journal of Pharmaceutics 2015; 493(1-2): 75 doi: 10.1016/j.ijpharm.2015.07.055
|
| 4 |
Jieun Kim, Yang H. Yun, Youngmi Jung. Biotechnologies for Gene Therapy. 2022; : 1 doi: 10.1007/978-3-030-93333-3_1
|
| 5 |
Walid Hamdy El-Tantawy, Abeer Temraz. Anti-fibrotic activity of natural products, herbal extracts and nutritional components for prevention of liver fibrosis: review. Archives of Physiology and Biochemistry 2022; 128(2): 382 doi: 10.1080/13813455.2019.1684952
|
| 6 |
Roland Böttger, Griffin Pauli, Po-Han Chao, Nojoud AL Fayez, Lukas Hohenwarter, Shyh-Dar Li. Lipid-based nanoparticle technologies for liver targeting. Advanced Drug Delivery Reviews 2020; : 79 doi: 10.1016/j.addr.2020.06.017
|
| 7 |
Nikita Hinge, Murali Monohar Pandey, Gautam Singhvi, Gaurav Gupta, Meenu Mehta, Saurabh Satija, Monica Gulati, Harish Dureja, Kamal Dua. Advanced 3D-Printed Systems and Nanosystems for Drug Delivery and Tissue Engineering. 2020; : 219 doi: 10.1016/B978-0-12-818471-4.00008-X
|
| 8 |
Omaima M. Abd El-Moneim, Abeer H. Abd El-Rahim, Naglaa A. Hafiz. Evaluation of selenium nanoparticles and doxorubicin effect against hepatocellular carcinoma rat model cytogenetic toxicity and DNA damage. Toxicology Reports 2018; 5: 771 doi: 10.1016/j.toxrep.2018.07.003
|
| 9 |
Leonard Kaps, Lutz Nuhn, Misbah Aslam, Alexander Brose, Friedrich Foerster, Sebastian Rosigkeit, Patricia Renz, Rosario Heck, Yong Ook Kim, Ingo Lieberwirth, Detlef Schuppan, Rudolf Zentel. In Vivo Gene‐Silencing in Fibrotic Liver by siRNA‐Loaded Cationic Nanohydrogel Particles. Advanced Healthcare Materials 2015; 4(18): 2809 doi: 10.1002/adhm.201500826
|
| 10 |
Dalia Dasgupta Mandal, Tamal Mandal, Moumita Hazra. Strategic approach in hepatic delivery of andrographolide: Key challenges and new insights. Journal of Herbal Medicine 2020; 24: 100411 doi: 10.1016/j.hermed.2020.100411
|
| 11 |
Seyedeh Alia Moosavian, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar, Giuseppe Ciccarella. The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review. Bioinorganic Chemistry and Applications 2021; 2021: 1 doi: 10.1155/2021/4041415
|
| 12 |
Tohada M. AL-Noshokaty, Noha M. Mesbah, Dina M. Abo-Elmatty, Ahmed I. Abulsoud, Asmaa R. Abdel-Hamed. Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis. Life Sciences 2022; 303: 120675 doi: 10.1016/j.lfs.2022.120675
|
| 13 |
Liyue Zhou, Yifan Li, Qiangwei Liang, Jinxia Liu, Yanhua Liu. Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review. Journal of Drug Targeting 2022; 30(6): 577 doi: 10.1080/1061186X.2022.2044485
|
| 14 |
Sara El-Safy, Salma N. Tammam, Mohammad Abdel-Halim, Mohamed E. Ali, John Youshia, Maryam A. Shetab Boushehri, Alf Lamprecht, Samar Mansour. Collagenase loaded chitosan nanoparticles for digestion of the collagenous scar in liver fibrosis: The effect of chitosan intrinsic collagen binding on the success of targeting. European Journal of Pharmaceutics and Biopharmaceutics 2020; 148: 54 doi: 10.1016/j.ejpb.2020.01.003
|
| 15 |
Shaimaa Ali Ali Radwan, Walaa H El-Maadawy, Carol Yousry, Aliaa Nabil ElMeshad, Raguia Aly Shoukri. <p>Zein/Phospholipid Composite Nanoparticles for Successful Delivery of Gallic Acid into aHSCs: Influence of Size, Surface Charge, and Vitamin A Coupling</p>. International Journal of Nanomedicine 2020; : 7995 doi: 10.2147/IJN.S270242
|
| 16 |
Hong Zhu, Changsheng He, Huizi Zhao, Wenjuan Jiang, Songbing Xu, Jun Li, Taotao Ma, Cheng Huang. Sennoside A prevents liver fibrosis by binding DNMT1 and suppressing DNMT1‐mediated PTEN hypermethylation in HSC activation and proliferation. The FASEB Journal 2020; 34(11): 14558 doi: 10.1096/fj.202000494RR
|
| 17 |
Jiaqi Chen, Yingrui Yao, Xiaoran Mao, Yuzhou Chen, Feng Ni. Liver-targeted delivery based on prodrug: passive and active approaches. Journal of Drug Targeting 2024; 32(10): 1155 doi: 10.1080/1061186X.2024.2386416
|
| 18 |
Tai-Long Pan, Pei-Wen Wang, Chi-Feng Hung, Ibrahim A. Aljuffali, You-Shan Dai, Jia-You Fang. The impact of retinol loading and surface charge on the hepatic delivery of lipid nanoparticles. Colloids and Surfaces B: Biointerfaces 2016; 141: 584 doi: 10.1016/j.colsurfb.2016.02.029
|
| 19 |
Raghda Hassan, Salma N. Tammam, Sara El Safy, Mohammad Abdel-Halim, Anastasia Asimakopoulou, Ralf Weiskirchen, Samar Mansour. Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis. European Journal of Pharmaceutics and Biopharmaceutics 2019; 134: 96 doi: 10.1016/j.ejpb.2018.11.018
|
| 20 |
Ching-Yun Hsu, Chun-Han Chen, Ibrahim A Aljuffali, You-Shan Dai, Jia-You Fang. Nanovesicle Delivery to the Liver Via Retinol Binding Protein and platelet-derived Growth Factor Receptors: How Targeting Ligands Affect Biodistribution. Nanomedicine 2017; 12(4): 317 doi: 10.2217/nnm-2016-0319
|
| 21 |
Qian-Qian Fan, Cheng-Lu Zhang, Jian-Bin Qiao, Peng-Fei Cui, Lei Xing, Yu-Kyoung Oh, Hu-Lin Jiang. Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy. Biomaterials 2020; 230: 119616 doi: 10.1016/j.biomaterials.2019.119616
|
| 22 |
Wei Peng, Shumin Cheng, Zhihang Bao, Youjing Wang, Wei Zhou, Junxian Wang, Qingling Yang, Changjie Chen, Wenrui Wang. Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis. Biomedicine & Pharmacotherapy 2021; 137: 111342 doi: 10.1016/j.biopha.2021.111342
|
| 23 |
Hung Thai Vu, Vien Duc Nguyen, Hiroko Ikenaga, Tsutomu Matsubara. Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment. Biomedicines 2024; 12(8): 1876 doi: 10.3390/biomedicines12081876
|
| 24 |
Wan-xia Li, Xin Chen, Yang Yang, Hui-min Huang, Hai-di Li, Cheng Huang, Xiao-ming Meng, Jun Li. Hesperitin derivative-11 suppress hepatic stellate cell activation and proliferation by targeting PTEN/AKT pathway. Toxicology 2017; 381: 75 doi: 10.1016/j.tox.2016.11.004
|
| 25 |
Xiao-Sa Du, Hai-Di Li, Xiao-Juan Yang, Juan-Juan Li, Jie-Jie Xu, Yu Chen, Qing-Qing Xu, Lei Yang, Chang-Sheng He, Cheng Huang, Xiao-Ming Meng, Jun Li. Wogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis. International Immunopharmacology 2019; 75: 105671 doi: 10.1016/j.intimp.2019.05.056
|
| 26 |
Simona Clichici, Luminita David, Bianca Moldovan, Ioana Baldea, Diana Olteanu, Mara Filip, Andras Nagy, Vlad Luca, Carmen Crivii, Petru Mircea, Gabriel Katona, Gabriela Adriana Filip. Hepatoprotective effects of silymarin coated gold nanoparticles in experimental cholestasis. Materials Science and Engineering: C 2020; 115: 111117 doi: 10.1016/j.msec.2020.111117
|
| 27 |
NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis. The International Journal of Biochemistry & Cell Biology 2016; 70: 92 doi: 10.1016/j.biocel.2015.11.010
|
| 28 |
Shaimaa Ali Ali Radwan, Walaa H. El-Maadawy, Aliaa Nabil ElMeshad, Raguia Aly Shoukri, Carol Yousry. Impact of Reverse Micelle Loaded Lipid Nanocapsules on the Delivery of Gallic Acid into Activated Hepatic Stellate Cells: A Promising Therapeutic Approach for Hepatic Fibrosis. Pharmaceutical Research 2020; 37(9) doi: 10.1007/s11095-020-02891-z
|
| 29 |
Manal G. Mahmoud, Mohsen S. Asker, Mohamed E. El Awady, Amal I. Hassan, Nadia A. R. Zaharan, Hanan F. Youssef. Effect of nanopolysaccharide (BSEPS) from Bacillus subtilis sp. on thioacetamide-induced liver fibrosis in rats. Bulletin of the National Research Centre 2019; 43(1) doi: 10.1186/s42269-019-0244-1
|
| 30 |
Sally A El Awdan, Gihan F. Asaad. Liver Fibrosis: Underlying Mechanisms and Innovative Therapeutic Approach. A Review Article. Biomedical and Pharmacology Journal 2021; 14(4): 1841 doi: 10.13005/bpj/2283
|
| 31 |
T.B. Salas-Villalobos, S.A. Lozano-Sepúlveda, A.R. Rincón-Sánchez, M. Govea-Salas, A.M. Rivas-Estilla. Mechanisms involved in liver damage resolution after hepatitis C virus clearance. Medicina Universitaria 2017; 19(75): 100 doi: 10.1016/j.rmu.2017.05.005
|
| 32 |
Hongliang Zhang, Qiuyan Huang, Zhenguang Huang, Taotao Liu, Yuanhong Li. Preparation and physicochemical properties of chitosan broadleaf holly leaf nanoparticles. International Journal of Pharmaceutics 2015; 479(1): 212 doi: 10.1016/j.ijpharm.2014.12.010
|
| 33 |
Virender Kumar, Ram I. Mahato. Delivery and Targeting of miRNAs for Treating Liver Fibrosis. Pharmaceutical Research 2015; 32(2): 341 doi: 10.1007/s11095-014-1497-x
|
| 34 |
Li Xiang, Xin Wang, Yaru Shao, Qiangqiang Jiao, Jiang Cheng, Xiaotong Zheng, Shaobing Zhou, Yuping Chen. Folate Decoration Supports the Targeting of Camptothecin Micelles against Activated Hepatic Stellate Cells and the Suppression of Fibrogenesis. ACS Applied Materials & Interfaces 2023; 15(1): 2030 doi: 10.1021/acsami.2c16616
|
| 35 |
Aiju Tian, Chengzhi Yang, Baoling Zhu, Wenjing Wang, Kai Liu, Yunqi Jiang, Yuhui Qiao, Haian Fu, Zijian Li. Polyethylene-glycol-coated gold nanoparticles improve cardiac function after myocardial infarction in mice. Canadian Journal of Physiology and Pharmacology 2018; 96(12): 1318 doi: 10.1139/cjpp-2018-0227
|
| 36 |
Huizi Zhao, Lin Wu, Yuan Zhang, Shiqi Feng, Yuhao Ding, Xin Deng, Rui Feng, Jun Li, Taotao Ma, Cheng Huang. Betulinic Acid Prevents Liver Fibrosis by Binding Lck and Suppressing Lck in HSC Activation and Proliferation. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4100257
|
| 37 |
Shubham A. Salunkhe, Deepak Chitkara, Ram I. Mahato, Anupama Mittal. Lipid based nanocarriers for effective drug delivery and treatment of diabetes associated liver fibrosis. Advanced Drug Delivery Reviews 2021; 173: 394 doi: 10.1016/j.addr.2021.04.003
|
| 38 |
Jie Kai Tee, Li Yang Ng, Hannah Yun Koh, David Tai Leong, Han Kiat Ho. Titanium Dioxide Nanoparticles Enhance Leakiness and Drug Permeability in Primary Human Hepatic Sinusoidal Endothelial Cells. International Journal of Molecular Sciences 2018; 20(1): 35 doi: 10.3390/ijms20010035
|
| 39 |
Matthew R. Golder, Jenny Liu, Jannik N. Andersen, Michail V. Shipitsin, Farrukh Vohidov, Hung V.-T. Nguyen, Deborah C. Ehrlich, Sung Jin Huh, Bhavatarini Vangamudi, Kyriakos D. Economides, Allison M. Neenan, James C. Ackley, Joelle Baddour, Sattanathan Paramasivan, Samantha W. Brady, Eric J. Held, Lawrence A. Reiter, Jennifer K. Saucier-Sawyer, Paul W. Kopesky, Donald E. Chickering, Peter Blume-Jensen, Jeremiah A. Johnson. Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs. Nature Biomedical Engineering 2018; 2(11): 822 doi: 10.1038/s41551-018-0279-x
|
| 40 |
Maritina Rouchota, Alessio Adamiano, Michele Iafisco, Eirini Fragogeorgi, Irineos Pilatis, Gilles Doumont, Sébastien Boutry, Daniele Catalucci, Argyro Zacharioudaki, George C. Kagadis. Optimization of In Vivo Studies by Combining Planar Dynamic and Tomographic Imaging: Workflow Evaluation on a Superparamagnetic Nanoparticles System. Molecular Imaging 2021; 2021 doi: 10.1155/2021/6677847
|
| 41 |
Advanced therapeutics avenues in hepatocellular carcinoma: a novel paradigm. Medical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02104-8
|
| 42 |
Md. Thohid Rayhan, Md. Aminul Islam, Moyeen Khan, Md. Abir Hasan, Md Hosne Mobarak, Md Israfil Hossain Rimon, Nayem Hossain. Advances in additive manufacturing of nanocomposite materials fabrications and applications. European Polymer Journal 2024; 220: 113406 doi: 10.1016/j.eurpolymj.2024.113406
|
| 43 |
Somayeh Mahdinloo, Seyed Hossein Kiaie, Ala Amiri, Salar Hemmati, Hadi Valizadeh, Parvin Zakeri-Milani. Efficient drug and gene delivery to liver fibrosis: rationale, recent advances, and perspectives. Acta Pharmaceutica Sinica B 2020; 10(7): 1279 doi: 10.1016/j.apsb.2020.03.007
|
| 44 |
Manjusha Bhange, Darshan Telange. Unlocking the Potential of Phyto Nanotherapeutics in Hepatocellular Carcinoma Treatment: A Review. Journal of Hepatocellular Carcinoma 2024; : 2241 doi: 10.2147/JHC.S483619
|
| 45 |
Mara Filip, Ioana Baldea, Luminita David, Bianca Moldovan, Gabriel Cristian Flontas, Sergiu Macavei, Dana Maria Muntean, Nicoleta Decea, Adrian Bogdan Tigu, Simona Valeria Clichici. Hybrid Material Based on Vaccinium myrtillus L. Extract and Gold Nanoparticles Reduces Oxidative Stress and Inflammation in Hepatic Stellate Cells Exposed to TGF-β. Biomolecules 2023; 13(8): 1271 doi: 10.3390/biom13081271
|
| 46 |
Hong Zhu, Huizi Zhao, Songbing Xu, Yuan Zhang, Yuhao Ding, Jun Li, Cheng Huang, Taotao Ma. Sennoside A alleviates inflammatory responses by inhibiting the hypermethylation of SOCS1 in CCl4-induced liver fibrosis. Pharmacological Research 2021; 174: 105926 doi: 10.1016/j.phrs.2021.105926
|
| 47 |
Jie Kai Tee, Fei Peng, Han Kiat Ho. Effects of inorganic nanoparticles on liver fibrosis: Optimizing a double-edged sword for therapeutics. Biochemical Pharmacology 2019; 160: 24 doi: 10.1016/j.bcp.2018.12.003
|
| 48 |
Bioinspired Nanocomposites: Applications in Disease Diagnosis and Treatment. Pharmaceutical Nanotechnology 2019; 7(3): 206 doi: 10.2174/2211738507666190425121509
|
| 49 |
Rong-Jane Chen, Hsiang-Hua Wu, Ying-Jan Wang. Strategies to prevent and reverse liver fibrosis in humans and laboratory animals. Archives of Toxicology 2015; 89(10): 1727 doi: 10.1007/s00204-015-1525-6
|
| 50 |
Sayali Pravin Metkar, Gasper Fernandes, Prerana D. Navti, Ajinkya N. Nikam, Ritu Kudarha, Namdev Dhas, Raviraja N Seetharam, Krishnan Venkata Santhosh, Bola Sadashiva Satish Rao, Srinivas Mutalik. Nanoparticle drug delivery systems in hepatocellular carcinoma: A focus on targeting strategies and therapeutic applications. OpenNano 2023; 12: 100159 doi: 10.1016/j.onano.2023.100159
|
| 51 |
Hussam Murad, Osama Ahmed, Tawfik Ghabrah, Mamdooh Gari. Telmisartan Self-Nanoemulsifying Drug Delivery System, Compared With Standard Telmisartan, More Effectively Improves Hepatic Fibrosis in Rats. Dose-Response 2020; 18(4) doi: 10.1177/1559325820982190
|
| 52 |
Imran Shahid, Qaiser Jabeen. Hepatitis C Virus-Host Interactions and Therapeutics: Current Insights and Future Perspectives. 2023; : 290 doi: 10.2174/9789815123432123010013
|
| 53 |
Jin-Kyu Park, Teruo Utsumi, Young-Eun Seo, Yang Deng, Ayano Satoh, William Mark Saltzman, Yasuko Iwakiri. Cellular distribution of injected PLGA-nanoparticles in the liver. Nanomedicine: Nanotechnology, Biology and Medicine 2016; 12(5): 1365 doi: 10.1016/j.nano.2016.01.013
|
| 54 |
Fei Peng, Jie Kai Tee, Magdiel Inggrid Setyawati, Xianguang Ding, Hui Ling Angie Yeo, Yeong Lan Tan, David Tai Leong, Han Kiat Ho. Inorganic Nanomaterials as Highly Efficient Inhibitors of Cellular Hepatic Fibrosis. ACS Applied Materials & Interfaces 2018; 10(38): 31938 doi: 10.1021/acsami.8b10527
|
| 55 |
Ezhilarasan Devaraj, S. Rajeshkumar. Nanoparticles and their Biomedical Applications. 2020; : 45 doi: 10.1007/978-981-15-0391-7_2
|
| 56 |
Samaneh Siapoush, Hanieh Mousazadeh, Ramazan Rezaei, Behzad Hatami, Sogol Mazhari, Naimeh Hashemi, Mohammad Reza Zali, Kaveh Baghaei. Oral targeted delivery of Imatinib by pH responsive copolymer modulates liver fibrosis in the mice model. International Journal of Pharmaceutics 2023; 641: 123068 doi: 10.1016/j.ijpharm.2023.123068
|
| 57 |
Moorthy Ganeshkumar, Thangavel Ponrasu, Muthaiya Kannappan Subamekala, Murthy Janani, Lonchin Suguna. Curcumin loaded on pullulan acetate nanoparticles protects the liver from damage induced by DEN. RSC Advances 2016; 6(7): 5599 doi: 10.1039/C5RA18989F
|
| 58 |
Sanvidhan G Suke, Prasad Sherekar, Vivek Kahale, Shaktipal Patil, Dharmendra Mundhada, Vivek M Nanoti. Ameliorative effect of nanoencapsulated flavonoid against chlorpyrifos‐induced hepatic oxidative damage and immunotoxicity in Wistar rats. Journal of Biochemical and Molecular Toxicology 2018; 32(5) doi: 10.1002/jbt.22050
|
| 59 |
Annelise M. Silva, Roger C. Grimm, Kevin J. Glaser, Yinlin Fu, Teresa Wu, Richard L. Ehman, Alvin C. Silva. Magnetic resonance elastography: evaluation of new inversion algorithm and quantitative analysis method. Abdominal Imaging 2015; 40(4): 810 doi: 10.1007/s00261-015-0372-5
|
| 60 |
Hojat Samarehfekri, Hamid Reza Rahimi, Mehdi Ranjbar. Controlled and cellulose eco-friendly synthesis and characterization of Bi2O2CO3 quantum dot nanostructures (QDNSs) and drug delivery study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78266-6
|
| 61 |
FUJI YANG, YAN HUANG, YOUWEN TAN, YONGMIN YAN. Ubiquitin-like posttranslational modifications in NAFLD progression and treatment. BIOCELL 2022; 46(2): 389 doi: 10.32604/biocell.2021.015899
|
| 62 |
Noura H Abd Ellah, Hesham M Tawfeek, James John, Helal F Hetta. Nanomedicine as a Future Therapeutic Approach for Hepatitis C Virus. Nanomedicine 2019; 14(11): 1471 doi: 10.2217/nnm-2018-0348
|
| 63 |
Daniel Sepúlveda-Crespo, José Luis Jiménez, Rafael Gómez, Francisco Javier De La Mata, Pedro L. Majano, Ma Ángeles Muñoz-Fernández, Pablo Gastaminza. Polyanionic carbosilane dendrimers prevent hepatitis C virus infection in cell culture. Nanomedicine: Nanotechnology, Biology and Medicine 2017; 13(1): 49 doi: 10.1016/j.nano.2016.08.018
|
| 64 |
Samah M. Ahmed, Shaimaa Ali Abdelrahman, Alaa Elsayed Salama. Efficacy of gold nanoparticles against isoproterenol induced acute myocardial infarction in adult male albino rats. Ultrastructural Pathology 2017; 41(2): 168 doi: 10.1080/01913123.2017.1281367
|
| 65 |
Huizi Zhao, Lin Wu, Yuan Zhang, Shiqi Feng, Yuhao Ding, Xin Deng, Rui Feng, Jun Li, Taotao Ma, Cheng Huang. Betulinic acid prevents liver fibrosis by binding Lck and suppressing Lck in HSC activation and proliferation. Journal of Ethnopharmacology 2022; 296: 115459 doi: 10.1016/j.jep.2022.115459
|
| 66 |
Shasha Zhu, Jiqian Zhang, Li Zhang, Wentao Ma, Na Man, Yiming Liu, Wei Zhou, Jun Lin, Pengfei Wei, Peipei Jin, Yunjiao Zhang, Yi Hu, Erwei Gu, Xianfu Lu, Zhilai Yang, Xuesheng Liu, Li Bai, Longping Wen. Inhibition of Kupffer Cell Autophagy Abrogates Nanoparticle‐Induced Liver Injury. Advanced Healthcare Materials 2017; 6(9) doi: 10.1002/adhm.201601252
|
| 67 |
Bishuang Cai, Paola Dongiovanni, Kathleen E. Corey, Xiaobo Wang, Igor O. Shmarakov, Ze Zheng, Canan Kasikara, Viralkumar Davra, Marica Meroni, Raymond T. Chung, Carla V. Rothlin, Robert F. Schwabe, William S. Blaner, Raymond B. Birge, Luca Valenti, Ira Tabas. Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis. Cell Metabolism 2020; 31(2): 406 doi: 10.1016/j.cmet.2019.11.013
|
| 68 |
Hans-Theo Schon, Matthias Bartneck, Erawan Borkham-Kamphorst, Jacob Nattermann, Twan Lammers, Frank Tacke, Ralf Weiskirchen. Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00033
|
| 69 |
Keqin Ji, Mingrui Fan, Dong Huang, Lingna Sun, Bingqin Li, Ruoting Xu, Jiajing Zhang, Xuan Shao, Yanzuo Chen. Clodronate-nintedanib-loaded exosome–liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity. Biomaterials Science 2022; 10(3): 702 doi: 10.1039/D1BM01663F
|
| 70 |
Gnyana Ranjan Parida, Gurudutta Pattnaik, Amulyaratna Behera. Cellular and Molecular Mechanism of Liver Fibrosis: A Critical Insight. Research Journal of Pharmacy and Technology 2021; : 6147 doi: 10.52711/0974-360X.2021.01066
|
| 71 |
Pengkai Wu, Xinping Luo, Meiling Sun, Beicheng Sun, Minjie Sun. Synergetic regulation of kupffer cells, extracellular matrix and hepatic stellate cells with versatile CXCR4-inhibiting nanocomplex for magnified therapy in liver fibrosis. Biomaterials 2022; 284: 121492 doi: 10.1016/j.biomaterials.2022.121492
|
| 72 |
Lin Chen, Wenyan Guo, Chun Mao, Jian Shen, Mimi Wan. Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents. Journal of Materials Chemistry B 2024; 12(6): 1446 doi: 10.1039/D3TB02790B
|
| 73 |
Shalini Shukla, Shalu Singh, Rahul Shukla. Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy. 2024; : 213 doi: 10.1016/B978-0-323-95303-0.00003-4
|